Get Quote
Get Quote
Pharmaceutical Grade Butylated hydroxyanisole (BHA) Pellets – Sustained Release and Multiparticulate Formulation
| Parameter | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.2% |
| Heavy Metals | NMT 10 ppm |
| pH (1% Solution) | 2.0 – 4.0 |
| Individual Impurity | ≤ 0.5% |
| Total Impurities | ≤ 1.5% |
Butylated hydroxyanisole (BHA) Pellets (CAS 37025-55-1) pellets are spherical or near-spherical multi-unit pharmaceutical dosage forms manufactured by extrusion-spheronisation or rotary granulation technology. Butylated hydroxyanisole (BHA) pellets enable precise dose uniformity, flexible drug loading, and controlled release coating applications, making them ideal for modified-release capsule formulations and multi-unit pellet systems (MUPS).
Quality specifications for Butylated hydroxyanisole (BHA) pellets include sphericity (aspect ratio <1.2), friability (<1%), particle size distribution (typically 500–1400 µm for capsule fill applications), and drug content uniformity per pharmacopeial dosage form specifications. Surface smoothness and low dust content are critical for film coating adhesion in extended-release pellet formulations.
Swapnroop Drugs and Pharmaceuticals manufactures Butylated hydroxyanisole (BHA) Pellets at our WHO-GMP Aurangabad facility using validated pelletisation technology with consistent sphericity and particle size control. Our pellet manufacturing supports modified-release capsule programs, MUPS tablet development, and speciality drug delivery programs for domestic and export markets.
Butylated hydroxyanisole (BHA) Pellets pellets are supplied in food-grade polyethylene bags (5 kg, 10 kg) inside fiber drums with desiccant to protect against moisture-induced dissolution and caking. Anti-static inner bags used for dust-sensitive pellet handling.
Get Bulk QuoteThe CAS number for Butylated hydroxyanisole (BHA) is 37025-55-1. Butylated hydroxyanisole (BHA) Pellets are multiparticulate pharmaceutical pellets manufactured for modified-release capsule and tablet formulations.
Butylated hydroxyanisole (BHA) Pellets are available in immediate-release (IR), sustained-release (SR), and enteric-coated (EC) release profiles. Dissolution data per target profile is provided with every batch.
Butylated hydroxyanisole (BHA) Pellets are manufactured in the 0.5–1.5 mm size range with tight size distribution verified by sieve analysis. Drug content uniformity (95–105% of label claim) is tested per USP/BP specifications.
MOQ for Butylated hydroxyanisole (BHA) Pellets is 1 kg for formulation development and 5–10 kg for commercial programs. Contact us for volume pricing and custom dissolution profile requirements.
Yes, Butylated hydroxyanisole (BHA) Pellets are designed for hard gelatin (HPMC) capsule filling and MUPS tablet compression. Pellet size distribution, bulk density, and flow properties are optimised for automated capsule filling equipment.
Swapnroop Drugs and Pharmaceuticals is a trusted Butylated hydroxyanisole (BHA) Pellets manufacturer and bulk supplier in Aurangabad, Maharashtra, serving pharmaceutical formulation companies across India and 25+ international markets. Our WHO-GMP certified facility provides consistent Butylated hydroxyanisole (BHA) Pellets supply with full pharmacopeial compliance, competitive pricing, and complete regulatory documentation for domestic and export programs.
As a Butylated hydroxyanisole (BHA) Pellets exporter from Maharashtra, India, Swapnroop supports pharmaceutical companies worldwide with DMF-grade documentation, Certificate of Analysis, MSDS, impurity profiles, and regulatory filing assistance for USFDA, EMA, and CDSCO submissions. Contact us for Butylated hydroxyanisole (BHA) Pellets pricing, samples, and sourcing support.